Stock Details
ABT is Abbott Laboratories's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 106.01$. Average daily volumn in 3 months 4.71M. Market cap 169.45B



Stock symbol : ABT. Exchange : NYSE. Currency : USD
Lastest price : 96.76$. Total volume : 6.33M. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

Abbott Laboratories (ABT)
Last Price
96.76$
Change
-1.53
Volume
6.33M

Previous Close98.29
Open98.71
Day Range96.67-99.50
Bid97.48 x 1.3k
Ask98.31 x 900
Volume6.33M
Average Volume4.71M
Market Cap169.45B
Beta0.71
52 Week Range96.67-142.60
Trailing P/E20.20
Foward P/E20.72
Dividend (Yield %)1.94%
Ex-Dividend Date2022-10-13



Financial Details


According to Abbott Laboratories's financial reports the company's revenue in 2021 were 43.08B an increase( +26.47%) over the years 2020 revenue that were of 34.61B. In 2021 the company's total earnings were 7.07B while total earnings in 2020 were 4.5B( +75%).


Loading ...



Organization

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecologi... cal disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Mรฉniรจre's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Market Cap:
169.45B
Revenue:
43.08B
Total Assets:
75.2B
Total Cash:
9.8B


News about "Abbott Laboratories"

when-abbott-laboratories-abt-moves-investors-should-listen-image

When Abbott Laboratories (ABT) Moves Investors should Listen

Source from : news.stocktradersdaily - 12 hours ago

When Abbott Laboratories ABT Moves Investors should Listen ...See details»


Here's Why Abbott Laboratories (NYSE:ABT) Has Caught The Eye Of Investors

Source from : YAHOO!Finance - 3 days ago

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good ...See details»


Abbott Laboratories Target of Unusually High Options Trading (NYSE:ABT)

Source from : Defense World - 2 days ago

Abbott Laboratories (NYSE:ABT โ€“ Get Rating) was the target of some unusual options trading on Thursday. Stock investors purchased 23,539 put options on the stock. This is an increase of approximately ...See details»


Abbott Laboratories Deadline Alert

Source from : MarketWatch - 7 days ago

If you suffered losses exceeding $100,000 investing in Abbott Laboratories stock or options between February 19, 2021 and June 8, 2022 and would like to discuss your legal rights, call Faruqi & Faruqi ...See details»


abbott-laboratories-nyseabt-shares-bought-by-global-retirement-partners-llc-image

Abbott Laboratories (NYSE:ABT) Shares Bought by Global Retirement Partners LLC

Source from : Defense World - 6 days ago

Global Retirement Partners LLC grew its stake in shares of Abbott Laboratories (NYSE:ABT โ€“ Get Rating) by 8.5% in the 2nd quarter, according to its most recent filing with the Securities & Exchange ...See details»


december-16th-options-now-available-for-abbott-laboratories-abt-image

December 16th Options Now Available For Abbott Laboratories (ABT)

Source from : Nasdaq - 10 days ago

Investors in Abbott Laboratories (Symbol: ABT) saw new options begin trading today, for the December 16th expiration. One of the key data points that goes into the price an option buyer is willing to ...See details»


Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years

Source from : Benzinga.com - 10 days ago

Abbott Laboratories ABT has outperformed the market over the past 10 years by 1.57% on an annualized basis producing an average annual return of 11.72%. Currently, Abbott Laboratories has a market ...See details»


Does Abbott Laboratories (NYSE:ABT) Deserve A Spot On Your Watchlist?

Source from : Yahoo - 11 days ago

Despite being in the age of tech-stock blue-sky investing, many investors still adopt a more traditional strategy; buying shares in profitable companies like Abbott Laboratories (NYSE:ABT).See details»


ABBOTT LABORATORIES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK

Source from : Associated Press - 11 days ago

Kahn Swick & Foti, LLC (โ€œKSFโ€) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 31, 2022 to file lead plaintiff applications ...See details»


Abbott Uses Spinal Cord Stimulation to Treat Pain in 6 Areas

Source from : MD&M East - 4 days ago

Abbott Laboratories has won FDA approval for a spinal cord stimulation system positioned to treat pain more effectively. The Abbott Park, IL-based company said the nod was for its Proclaim Plus SCS ...See details»


FDA outlines flaws in how it handled formula shortage linked to Abbott recalls

Source from : Crain's Chicago Business - 11 days ago

The U.S. Food & Drug Administration is criticizing Abbott Laboratories for conditions at a factory tied to a nationwide recall of baby formula. A new FDA report said conditions it observed at ...See details»


FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Abbott Laboratories - ABT

Source from : Benzinga.com - 3 days ago

The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Abbott Laboratories (NYSE:ABT), if they purchased the Company's shares ...See details»


Abbott Laboratories Company Profile โ€“ Key Financials | Annual Revenue (USD 43,075 Mn)

Source from : PharmiWeb - 12 days ago

Abbott Laboratories is involved in the discovery, development and manufacturing of a variety of healthcare products. These are the segments it operates in. The Established Pharmaceutical Products ...See details»


Global Vitamin D Testing Market (2022 to 2027) - Featuring Abbott Laboratories, Biokit, bioMerieux and Danaher Among Others - ResearchAndMarkets.com

Source from : Daily Herald - 3 days ago

The Global Vitamin D Testing Market is estimated to be worth USD 632 million in 2022, and is expected to reach USD 837.81 million by 2027, growing at a CAGR of 5.8%. Market dynamics are forces that ...See details»